S Mörk

1.9k total citations
36 papers, 1.4k citations indexed

About

S Mörk is a scholar working on Genetics, Molecular Biology and Neurology. According to data from OpenAlex, S Mörk has authored 36 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 9 papers in Molecular Biology and 7 papers in Neurology. Recurrent topics in S Mörk's work include Glioma Diagnosis and Treatment (10 papers), Meningioma and schwannoma management (5 papers) and Multiple Sclerosis Research Studies (3 papers). S Mörk is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), Meningioma and schwannoma management (5 papers) and Multiple Sclerosis Research Studies (3 papers). S Mörk collaborates with scholars based in Norway, United States and United Kingdom. S Mörk's co-authors include Lars Bø, Harald Nyland, Christian A. Vedeler, Bruce D. Trapp, Paul van der Valk, Jeroen J.G. Geurts, Karl-Fredrik Lindegaard, Geir Egil Eide, Tore Halvorsen and Elling Ulvestad and has published in prestigious journals such as Journal of Neurology Neurosurgery & Psychiatry, Acta Neuropathologica and Journal of Neuropathology & Experimental Neurology.

In The Last Decade

S Mörk

33 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Mörk Norway 19 466 461 345 328 224 36 1.4k
Benjamin Ellezam Canada 18 401 0.9× 425 0.9× 647 1.9× 358 1.1× 236 1.1× 51 1.9k
Emanuela Zappia Italy 7 261 0.6× 959 2.1× 411 1.2× 110 0.3× 121 0.5× 8 1.6k
Bernd W. Scheithauer United States 23 312 0.7× 960 2.1× 397 1.2× 577 1.8× 43 0.2× 38 2.3k
K. Kitz Austria 32 276 0.6× 1.2k 2.6× 426 1.2× 1.1k 3.4× 192 0.9× 91 4.0k
Amilcar A. Castellano‐Sanchez United States 14 159 0.3× 959 2.1× 696 2.0× 1.0k 3.2× 172 0.8× 37 2.1k
Iwao Takeshita Japan 27 126 0.3× 847 1.8× 515 1.5× 697 2.1× 124 0.6× 93 2.0k
Marie Théaudin France 22 391 0.8× 131 0.3× 779 2.3× 473 1.4× 90 0.4× 79 1.6k
Andreas Junker Germany 22 601 1.3× 113 0.2× 759 2.2× 320 1.0× 357 1.6× 52 1.9k
W. Shawn Carbonell United States 15 87 0.2× 346 0.8× 706 2.0× 248 0.8× 164 0.7× 17 1.7k
Uğur Özerdem United States 23 126 0.3× 336 0.7× 1.2k 3.6× 132 0.4× 275 1.2× 59 2.4k

Countries citing papers authored by S Mörk

Since Specialization
Citations

This map shows the geographic impact of S Mörk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Mörk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Mörk more than expected).

Fields of papers citing papers by S Mörk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Mörk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Mörk. The network helps show where S Mörk may publish in the future.

Co-authorship network of co-authors of S Mörk

This figure shows the co-authorship network connecting the top 25 collaborators of S Mörk. A scholar is included among the top collaborators of S Mörk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Mörk. S Mörk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jian, Inderjit Daphu, Hrvoje Miletić, et al.. (2010). A novel brain metastases model developed in immunodeficient rats closely mimics the growth of metastatic brain tumours in patients. Neuropathology and Applied Neurobiology. 37(2). 189–205. 26 indexed citations
2.
Krüger, P.G., et al.. (2009). Mast cells and multiple sclerosis: a light and electron microscopic study of mast cells in multiple sclerosis emphasizing staining procedures. Acta Neurologica Scandinavica. 81(1). 31–36. 26 indexed citations
3.
Scheie, David, Milada Cvancarova, S Mörk, et al.. (2008). Can morphology predict 1p/19q loss in oligodendroglial tumours?. Histopathology. 53(5). 578–587. 22 indexed citations
4.
Krohn, Jørgen, et al.. (2007). Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation. Eye. 22(11). 1398–1403. 26 indexed citations
5.
Mörk, S, et al.. (2007). A girl with spina bifida, an extra leg, and ectopic intestinal loops – a “foetus in foetu” or a whim of the neural crest?. Acta Neurochirurgica. 149(10). 1071–1075. 10 indexed citations
6.
Bø, Lars, Jeroen J.G. Geurts, S Mörk, & Paul van der Valk. (2006). Grey matter pathology in multiple sclerosis. Acta Neurologica Scandinavica. 113(s183). 48–50. 117 indexed citations
7.
Giannini, Caterina, B. W. Scheithauer, Amy L. Weaver, et al.. (2001). Oligodendrogliomas: Reproducibility and Prognostic Value of Histologic Diagnosis and Grading. Journal of Neuropathology & Experimental Neurology. 60(3). 248–262. 158 indexed citations
8.
Romi, Fredrik, et al.. (2000). [Diffusion-weighted magnetic resonance tomography--a new instrument in the diagnosis of Creutzfeldt-Jakob disease].. PubMed. 120(6). 675–7. 2 indexed citations
9.
Storstein, Anette, Christian A. Vedeler, Bård Kronen Krossnes, & S Mörk. (1997). [Paraneoplastic cerebellar degeneration. A case report].. PubMed. 117(20). 2947–8.
10.
Ganz, Jeremy C., Sylvi Aanderud, S Mörk, & Alf Inge Smievoll. (1994). Tumour Volume Reduction Following Gamma Knife Radiosurgery: The Relationship Between X-ray and Histological Findings. Acta neurochirurgica. Supplementum. 62. 39–42. 7 indexed citations
11.
Vedeler, Christian A., Elling Ulvestad, Line Bjørge, et al.. (1994). The expression of CD59 in normal human nervous tissue.. PubMed. 82(4). 542–7. 57 indexed citations
12.
Ulvestad, Elling, Kenneth C. Williams, Lars Eirik Bø, et al.. (1994). HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro.. PubMed. 82(4). 535–41. 67 indexed citations
13.
Bø, Lars, Carlos A. Pardo, S Mörk, & Bruce D. Trapp. (1993). MICROGUAL CHANGES IN MULTIPLE SCLEROSIS LESIONS. Journal of Neuropathology & Experimental Neurology. 52(3). 331–331. 1 indexed citations
14.
Bø, Lars, S Mörk, & Harald Nyland. (1992). An immunohistochemical study of mononuclear cells in meningiomas. Neuropathology and Applied Neurobiology. 18(6). 548–558. 43 indexed citations
15.
Borgis, K., et al.. (1991). Klinische und neuroradiologische Befunde bei Gliomatosis cerebri unter Berücksichtigung der Magnetresonanztomographie. Klinische Pädiatrie. 203(5). 345–349. 3 indexed citations
16.
Engebraaten, Olav, Rolf Bjerkvig, Morten Lund‐Johansen, et al.. (1990). Interaction between human brain tumour biopsies and fetal rat brain tissue in vitro. Acta Neuropathologica. 81(2). 130–140. 55 indexed citations
17.
Helseth, Are & S Mörk. (1989). Neoplasms of the central nervous system in Norway. III. Epidemiological characteristics of intracranial gliomas according to histology.. PubMed. 97(6). 547–55. 37 indexed citations
18.
Bjerkeset, T, Inge Morild, S Mörk, & Odd Söreide. (1987). Tumor characteristics in colorectal cancer and their relationship to treatment and prognosis. Diseases of the Colon & Rectum. 30(12). 934–938. 44 indexed citations
19.
Hofstad, Håkon, et al.. (1987). [Myasthenia gravis with myocarditis and sudden death].. PubMed. 107(15). 1322–3, 1345. 1 indexed citations
20.
Ridder, Leo De, et al.. (1982). Invasiveness of human neurogenic cell lines in vitro. Ghent University Academic Bibliography (Ghent University). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026